Teva Pharmaceutical Industries (TEVA) Tax Rate (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) has reported Tax Rate for 18 consecutive years, with 15.33% the latest figure, recorded in Q1 2026.

• Quarterly Tax Rate fell 984.0% year-over-year to 15.33% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.69% (up 13947.0% YoY) and the FY2025 annual result came in at 14.72%, up 3793.0% from the prior year.
• Tax Rate grew to 15.33% in Q1 2026 per TEVA's latest filing, from 487.5% in the prior quarter.
• Over the last five years, Tax Rate for TEVA reached as high as 76.4% in Q2 2022 and fell as low as 487.5% in Q4 2025.
• A 5-year average of 37.55% and a median of 2.34% in 2023 frame the typical range for Tax Rate.
• The largest YoY upside for Tax Rate was 21767 bps in 2025 against a maximum downside of 47616 bps in 2025.
• Year by year, Tax Rate stood at 12.57% in 2022, then surged by 81 bps to 2.34% in 2023, then tumbled by 385 bps to 11.34% in 2024, then sank by 4200 bps to 487.5% in 2025, then jumped by 103 bps to 15.33% in 2026.
• According to Business Quant data, Tax Rate over the past three periods registered 15.33%, 487.5%, and 33.13% for Q1 2026, Q4 2025, and Q3 2025 respectively.